Zobair Younossi, MD, MPH

Article

Treatment options for nonresponders and relapsers to initial therapy for hepatitis C

Author:: Zobair Younossi, MD, MPH

Publish date: September 1, 2003

Article

Advances in treatment of chronic hepatitis C: 'Pegylated' interferons

Author:: Zobair Younossi, MD, MPH

Publish date: February 1, 2002

New formulations of interferon alfa that incorporate polyethylene glycol in the drug molecule are an important advance in the treatment of chronic ...

Article

Treatment strategies for hepatitis C: Making the best of limited options

Author:: Zobair Younossi, MD, MPH

Publish date: July 1, 2000

With interferon and ribavirin therapy, 40% of patients with hepatitis C can be cured. Determining the genotype of the virus can help guide therapy....